How big is the target – and does it really fit NST?
Snapshot (June 2025)
Minerals 260 (MI6)
Northern Star (NST)
1 Market cap
≈ A$240 m @ A$0.12/sh
≈ A$24 bn
2 Flagship asset
100 % Bullabulling, 2.3 Moz Au (JORC 2012) near Coolgardie
KCGM “Super‑Pit”, Yandal, Pogo (USA) + newly acquired Hemi (via De Grey)
3 Corporate goal
Build a standalone CIL plant and become a mid‑tier producer
“Fill & feed” strategy: extend KCGM’s life, add >10 Moz in WA
1 – Who controls the scrip today?
Holder (Top‑20, Apr 2025)
% issued capital
1 HSBC, JPM & Citi nominee lines (institutional custodians)
42 %
2 Tim Goyder (Executive Chair)
6.1 %
3 Norton Gold Fields (Zijin)
3.9 %
4 Other top‑20 + free‑float
48 %
2 – What would have to happen before NST moves?
Stage
Catalyst
Earliest timing
Relevance to NST
1 Resource growth
80 000 m drill program + Dec 2025 MRE update
Q4 2025
NST usually buys at >3–4 Moz for +10 yr life
2 Metallurgy & scoping
Phase‑1 met + open‑pit shells at A$5 000–A$6 000/oz
H1 2026
Confirms CIL compatibility with KCGM circuits
3 PFS / Permit pathway
Early works, tailings approval, haul‑road options
2026‑27
The later MI6 de‑risks, the higher the price – NST may pre‑empt
4 NST balance‑sheet digestion
De Grey integration, KCGM mill expansion
2025‑26
12–18 mths bedding‑down; a sub‑A$1 bn bolt‑on is still doable
5 Stake‑building window
NST begins 5 %+ on‑market purchases
Any time after strong drill hits
Earliest visible sign; price would re‑rate
3 – Probability matrix (qualitative)
Horizon
Key gating factor
Likelihood of bid
Comment
1 0–12 mths (→ Jun 26)
Resource <3 Moz; NST digesting De Grey
~15 % (Low)
Attractive price but sparse data; MI6 board focused on self‑build
2 12–24 mths (→ Jun 27)
>3.5 Moz MRE; initial scoping done
25–35 % (Moderate)
Classic window for friendly scheme once de‑risked
3 2–5 yrs (→ 2030)
DFS complete or MI6 project financing
45–60 % (Med‑High)
If gold >A$5 000/oz persists, selling to NST logical
4 – Wildcards that raise / lower the odds
Upside to a takeover
Downside / defence tools
1 • Bullabulling lifts to >5 Moz or >1.4 g/t, boosting NPV above A$1 bn
• Goyder factor – experienced builder; could resist a lowball offer
2 • WA haul‑road & permitting easier than Pilbara builds
• Norton (Zijin) 3.9 % stake complicates all‑scrip deal
3 • Gold price >A$6 000/oz stretches KCGM mill faster
• MI6 secures project finance or toll‑milling MoU elsewhere
Bottom line
• Near‑term (≤ 12 mths): A raid is possible but unlikely – NST is busy bedding‑in Hemi and KCGM expansion; MI6 still proving ounces.
• Medium‑term (2026‑27): A ≥ 3.5 Moz upgrade and positive scoping would make a friendly scheme at ~A$0.30–0.35/sh logical (<A$800 m outlay).
• Longer‑term (post‑DFS): If MI6 faces ~A$500 m capex, selling to a cashed‑up producer becomes the path of least resistance.Estimated probability of an NST bid succeeding by 2027: ~30 %.
Probability by 2030 if MI6 remains independent: ~50 %+.
Watch for: substantial‑holder notices >5 %, standout drill intercepts above 2 g/t, or any MI6‑NST “infrastructure cooperation” announcement.
- Forums
- ASX - By Stock
- MI6
- Charts & TA
MI6
minerals 260 limited
Add to My Watchlist
4.17%
!
11.5¢

Charts & TA, page-253
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
11.5¢ |
Change
-0.005(4.17%) |
Mkt cap ! $237.7M |
Open | High | Low | Value | Volume |
12.0¢ | 12.5¢ | 11.5¢ | $400.6K | 3.358M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
24 | 3378868 | 11.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
12.0¢ | 363684 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
24 | 3378868 | 0.115 |
17 | 2772900 | 0.110 |
10 | 490342 | 0.105 |
12 | 1295000 | 0.100 |
1 | 10000 | 0.099 |
Price($) | Vol. | No. |
---|---|---|
0.120 | 363684 | 3 |
0.125 | 1167744 | 11 |
0.130 | 2239535 | 9 |
0.135 | 379416 | 9 |
0.140 | 634668 | 11 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
MI6 (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online